logo     Print Page | Close Window

SEC Filings

EQUINIX INC filed this Form 424B5 on 02/28/2019
Entire Document

Table of Contents

Prospectus Supplement

(To Prospectus Dated November 7, 2017)



Common Stock



We are offering 2,596,153 shares (the “firm shares”) of our common stock, par value $0.001 per share (our “common stock”). We will receive all of the net proceeds from this offering.

Our common stock is listed on the Nasdaq Global Select Market (the “Nasdaq”) under the symbol “EQIX.” On February 27, 2019, the last reported sale price of our common stock on the Nasdaq was $418.15 per share.




Investing in our common stock involves risks. See “Risk Factors” beginning on page S-7 of this prospectus supplement, as well as the risks described in “Risk Factors” in our most recent Annual Report on Form 10-K, which is incorporated by reference into this prospectus supplement and the accompanying prospectus.


     Per Share      Total  

Public offering price(1)

   $ 416.00      $ 1,079,999,648  

Underwriting discounts and commissions(1)

   $ 9.36      $ 24,299,992  

Proceeds, before expenses, to Equinix, Inc.(1)

   $ 406.64      $ 1,055,699,656  



Assumes no exercise of the underwriters’ option to purchase additional shares as described below.

We have granted the underwriters an option exercisable within a 30-day period beginning on, and including, the date of this prospectus supplement, to purchase up to 389,422 additional shares of our common stock (the “additional shares” and, together with the firm shares, the “shares”) from us at the public offering price, less the underwriting discounts and commissions, and less an amount per share equal to any per share dividends that are paid or payable by us on the firm shares but that are not payable on the additional shares.

Prior to purchasing the common stock being offered pursuant to this prospectus supplement, on February 27, 2019, one of the underwriters purchased, on behalf of the syndicate, 6,511 shares of our common stock at an average price of $418.00 per share in stabilizing transactions.

Neither the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The underwriters expect to deliver the shares on or about March 4, 2019.



Joint Book-Running Managers


Citigroup   J.P. Morgan   Morgan Stanley   Goldman Sachs & Co. LLC
Barclays   BofA Merrill Lynch   MUFG   RBC Capital Markets



HSBC   ING   Mizuho Securities   TD Securities   Wells Fargo Securities
BNP PARIBAS   BTIG   PNC Capital Markets LLC   Scotiabank   SMBC

EA Markets



February 27, 2019